|
RPL28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68254299381942E-12 |
| Normal-vs-Stage2 |
2.224000E-04 |
| Normal-vs-Stage3 |
3.8668000000075E-05 |
| Normal-vs-Stage4 |
6.838900E-04 |
| Stage1-vs-Stage2 |
8.010600E-01 |
| Stage1-vs-Stage3 |
2.514200E-01 |
| Stage1-vs-Stage4 |
1.737550E-02 |
| Stage2-vs-Stage3 |
2.507200E-01 |
| Stage2-vs-Stage4 |
1.524200E-02 |
| Stage3-vs-Stage4 |
4.175800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.79919992635303E-10 |
| Normal-vs-Asian |
3.685700E-02 |
| Caucasian-vs-AfricanAmerican |
5.727800E-01 |
| Caucasian-vs-Asian |
2.003200E-01 |
| AfricanAmerican-vs-Asian |
1.755790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
4.44389969267434E-10 |
| Male-vs-Female |
4.064600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.70229999885541E-08 |
| Normal-vs-Extreme_Weight |
1.62925228863742E-12 |
| Normal-vs-Obese |
2.25089946681578E-11 |
| Normal-vs-Extreme_Obese |
3.338300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.090800E-01 |
| Normal_Weight-vs-Obese |
7.793200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.980100E-03 |
| Extreme_Weight-vs-Obese |
6.366400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.296950E-03 |
| Obese-vs-Extreme_Obese |
9.758600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96741999999306E-05 |
| Normal-vs-Age(41-60Yrs) |
2.54885001993443E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
7.154400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.759300E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.831360E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.543550E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.676000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.278000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.867600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
8.11180000948042E-09 |
| Normal-VS-KIRP CIMP |
1.175090E-04 |
| Normal-VS-Unclassified PRCC |
2.022800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.803200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.03700000031459E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.056390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.21899999983022E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.852800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.54419999998101E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9311999494297E-09 |
| Normal-vs-N1 |
2.76359999995535E-06 |
| Normal-vs-N2 |
9.200000E-03 |
| N0-vs-N1 |
2.636200E-02 |
| N0-vs-N2 |
7.384100E-03 |
| N1-vs-N2 |
4.390800E-01 |
|
|
